Legal questions swirl around FDA's new expedited drug program, including who should sign off - AP News
A plan to slash Food and Drug Administration drug review times is raising alarms at the public health agency that's been rocked by recent layoffs and resignations. Agency staffers and outside experts worry the FDA commissioner's voucher program runs afoul of …... Read More
Source: Associated Press
Published: 2026-01-16T19:12:00Z
Author: Matthew Perrone